Literature DB >> 15306821

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.

Sung Hee Um1, Francesca Frigerio, Mitsuhiro Watanabe, Frédéric Picard, Manel Joaquin, Melanie Sticker, Stefano Fumagalli, Peter R Allegrini, Sara C Kozma, Johan Auwerx, George Thomas.   

Abstract

Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306821     DOI: 10.1038/nature02866

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  703 in total

1.  Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, obese Zucker rats.

Authors:  Zhuyun Li; Cory M Dungan; Bradley Carrier; Todd C Rideout; David L Williamson
Journal:  Lipids       Date:  2014-11-01       Impact factor: 1.880

Review 2.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

3.  S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy.

Authors:  Catherine Espeillac; Claudia Mitchell; Séverine Celton-Morizur; Céline Chauvin; Vonda Koka; Cynthia Gillet; Jeffrey H Albrecht; Chantal Desdouets; Mario Pende
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

4.  Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Authors:  Mitsuhiro Watanabe; Yasushi Horai; Sander M Houten; Kohkichi Morimoto; Taichi Sugizaki; Eri Arita; Chikage Mataki; Hiroyuki Sato; Yusuke Tanigawara; Kristina Schoonjans; Hiroshi Itoh; Johan Auwerx
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

5.  Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function.

Authors:  Klaas Romanino; Laetitia Mazelin; Verena Albert; Agnès Conjard-Duplany; Shuo Lin; C Florian Bentzinger; Christoph Handschin; Pere Puigserver; Francesco Zorzato; Laurent Schaeffer; Yann-Gaël Gangloff; Markus A Rüegg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 6.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

7.  Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle.

Authors:  Pengxiang She; Tanya M Reid; Sarah K Bronson; Thomas C Vary; Andras Hajnal; Christopher J Lynch; Susan M Hutson
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 9.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

10.  Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.

Authors:  Antonella Caccamo; Ramona Belfiore; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2018-04-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.